Track Integer Holdings Corporation — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Integer Holdings Corporation ITGR · Stock Open Integer Holdings Corporation in new tab

126.70 USD
P/E
42.52
EPS
2.98
P/B
2.50
ROE
5.97
Beta
0.58
Loading chart...
Key Metrics
Earnings dateFeb. 18, 2027
P/E42.52
EPS2.98
Book Value50.78
Price to Book2.50
Debt/Equity77.88
% Insiders3.415%
Growth
Revenue Growth-0.04%
Earnings Growth-0.61%
Estimates
Forward P/E18.45
Forward EPS6.87

DCF valuation

Model fair value for Integer Holdings Corporation (ITGR)
Result
Sign in to run the valuation for ITGR.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–

Integer Holdings Corporation Logo Integer Holdings Corporation Analysis (ITGR)

United States Health Care Official Website Stock

Is Integer Holdings Corporation a good investment? Integer Holdings Corporation (ITGR) is currently trading at 126.70 USD.

In terms of valuation, the stock trades at a P/E ratio of 42.52. This high multiple suggests investors have priced in significant future growth expectations.

Earnings Schedule: Integer Holdings Corporation is expected to release its next earnings report on Feb. 18, 2027. The market consensus estimate for Forward EPS is 6.87.

Investor FAQ

Does Integer Holdings Corporation pay a dividend?

No, it does not currently pay a dividend.

What asset class is Integer Holdings Corporation?

Integer Holdings Corporation is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Feb. 18, 2027. The company currently has a trailing EPS of 2.98.

Company Profile

Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; implanted medical devices, implanted leads, procedure accessories, and external devices; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; orthopedics, minimally invasive surgery, and general surgery devices; and portable medical devices, including patient monitoring, ventilators, portable defibrillators, portable ultrasound, and X-Ray machines. Furthermore, the company provides medical technologies; supplies medical stamped components, and shallow and deep draw casings and assemblies; and epicardial pacing leads. It serves multi-national original equipment manufacturers and affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, cardio and vascular, and advanced surgical and portable medical markets. The company provides its products under the Greatbatch Medical and the Lake Region Medical brands. The company was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

Exchange Ticker
FRA (Germany) WGB.F
NYQ (United States) ITGR
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion